Reprogramming the Tumor Microenvironment via TFF3 Targeting: A Potential Novel Avenue to Boost CAR-T Cell Therapy in Solid Tumors

The authors explore how TFF3 signaling contributes to tumor progression and immune escape, and how its inhibition might reshape the tumor microenvironment (TME) to better support CAR-T cell activity